Crisis in Access to Essential Medicines in India: Key Issues for Action

An Unethical and Unwanted Assurance

Cleaning up the Pharma Industry: Ban on Irrational FDCs

A Law that Needs Much more than a Cosmetic Change?

Is the Government Mulling a Surgical strike on Medicines?

Prescribing Generic Medicines

Indian Govt may ask Doctors to Prescribe Medicines under Generic Name: Is it Practical?

What's in a Generic Name

Obituary Dr Ranjit Roy Chaudhury

Ethical Minefield: Pharma Industry's Gifts to Doctors

AIDAN Press Release on Generic Precriptions

Quality, Safety and Efficacy of Drugs

The Impact of GST on Medicine Prices

Misreading the Pharma Market

How to make the new Pharma Price Index a Healthy Model

Not the Right Prescription for Affordable Healthcare

FDC Ban and Endless Rounds of Litigation

FDCs and their Ban: Issues of Concern

Bad news for Patients as the Govt Weakens the Drug Price Regulator and meddles with Price Caps

Anticancer Drugs: Capping Trade Margins is not Enough

India's New Clinical Trial Rules weakens Safety Nets for Participants

Manifestos Duck Core Pharma Issues

The bitter side of India’s pharma story

The Oxytocin Ban: Judgment and Legal Issues

Of judicial reviews, legislative decisions and scientific matters

CHIM Method of Vaccine Testing is no shot in the arm for India

Oxytocin Case - the issues and the High Court and Supreme Court order

HCQ Diplomacy

Healthcare should always be available

The vaccine mandates judgment: some reflections

Why do unethical pharma practices thrive?